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Background: Cytokines secreted by adipose tissue macrophages (ATMs) significantly alter adipocyte function,
inducing inflammatory responses and decreasing insulin sensitivity. However, little relevant information is available
regarding the role of microvesicles (MVs) derived from ATMs in macrophage-adipocyte crosstalk.
Methods: MVs were generated by stimulation of M1 or M2 phenotype THP-1 macrophages and incubated with
human primary mature adipocytes and differentiated adipocytes. Subsequently, insulin-stimulated phosphorylation
of Akt (pAkt) and glucose uptake were determined. Glucose transporter 4 (GLUT4) translocation and nuclear
translocation of nuclear factor (NF)-kappa B were also analyzed in treated adipocytes.
Results: M1 macrophage-derived MVs (M1 MVs) significantly reduced protein abundance of insulin-induced Akt
phosphorylation in human primary mature adipocytes and differentiated adipocytes, when compared with the same
concentration of M2 macrophage-derived MVs (M2 MVs). In contrast to M2 MVs, which enhanced the insulin-induced
glucose uptake measured by 2-NBDG, M1 MVs decreased this effect in treated adipocytes. M1 MVs treatment also
brought about a significant increase in the nuclear translocation of nuclear factor (NF)-kappa B, coupled with a
decrease in pAkt level and GLUT4 translocation compared with M2 MVs-treated adipocytes. These effects were
reversed by BAY 11–7085, a NF- kappa B specific inhibitor.
Conclusions: MVs derived from proinflammatory (M1) macrophages may, at least in part, contribute to the
pathogenesis of obesity-induced insulin resistance, reducing insulin signal transduction and decreasing glucose
uptake in human adipocytes, through NF-kappa B activation. Therefore, these MVs may be potential therapy
candidates for the management of type 2 diabetes mellitus.
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Obesity-induced insulin resistance is a key component
in the pathogenesis of type 2 diabetes (T2D) [1]. Adipose
tissue macrophages (ATMs) are necessary and sufficient
for the development of the adipose tissue (AT) inflam-
mation and insulin resistance associated with obesity
[2]. The general understanding is that ATMs are
mainly subdivided into M1 (classically activated or
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creativecommons.org/publicdomain/zero/1.0/anti-inflammatory) phenotypes, wherein M1 ATMs
show a pro-inflammatory character, whereas M2 ATMs
exhibit an anti-inflammatory phenotype [3, 4]. Increas-
ing evidence has demonstrated that the cytokines [e.g.,
tumor necrosis factor-α (TNF-α) [5], interleukin-1β
(IL-1β) [6], interleukin-6 [7] secreted by M1 ATMs can
modify adipocyte function, such as activating inflam-
matory pathways [8] and impairing insulin action [9].
However, whether cytokines are the only factors for
the induction of insulin resistance remains unclear.
Microvesicles (MVs), also known as extracellular vesi-
cles, microparticles, exosomes, or shedding vesicles, are
small (30–1000 nm) membrane-bound particles released
from eukaryotic cells under normal physiological and
pathological conditions. They play a pivotal role in medi-
ating cell-to-cell communication [10]. Mesenchymal stemticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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tivation at type 1 diabetes onset [11]. MVs derived from
apoptotic endothelial cells [12], activated platelets [13] or
monocytes [14] can act as cellular effectors, disseminating
pro-inflammatory potential in vascular inflammation,
which may contribute to vascular diseases and diabetic
cardiovascular complications. Our previous studies
[15] and others [16] have further shown that MVs re-
leased from inflamed monocytes/macrophages may
represent a class of inflammatory factors involved in
the inflammatory process associated with metabolic
diseases. MVs secreted from monocytes can promote
angiogenesis in vitro and in vivo, which may serve as a
novel therapeutic approach for many angiogenesis-
related diseases such as cancers and diabetes [17]. Fur-
thermore, growing evidence is demonstrating that
monocyte/macrophage-derived MVs play crucial roles
in the pathogenesis of inflammatory diseases through
up-regulation of proinflammatory mediators, such as
nuclear factor (NF)-κB [18, 19]. MVs released by
adipocytes play a major role in the crosstalk between
adipocytes and macrophages; this crosstalk is now rec-
ognized as a major mechanism in adipose tissue in-
flammation and a key contributor to insulin resistance
[20, 21]. The possibility remains that monocyte/macro-
phage-secreted MVs can inhibit insulin signaling in adipo-
cytes, thereby causing the insulin resistance observed in
obese adipose tissue.
In the current study, we characterized MVs shed by
in vitro polarized THP-1 macrophages with both M1
and M2 phenotypes, and evaluated their ability to in-
fluence insulin signaling and glucose uptake in human
primary mature adipocytes and primary differentiated
adipocytes through activation of NF-κB. The data re-
ported here may expand our knowledge the role of
macrophage-derived microvesicles in the crosstalk
between macrophages and adipocytes, and provide




Subcutaneous abdominal tissue specimens of human
white fat were obtained from nondiabetic females with a
BMI of less than 25. Written informed consent was ob-
tained from each patient before the study. All studies
were performed with the approval of the Ethics Commit-
tee of Nanjing Medical University.
Isolation, cultivation, and differentiation of preadipocytes
Human primary preadipocyte cultures were prepared as
previously described, with minor modifications [22].
Samples of adipose tissue (AT) were washed with PBS
supplemented with gentamycin and then digested withcollagenase I (1–1.5 g/L, Sigma) for 40–60 min in a shaking
water bath at 37 °C. The digest was then filtered
through 200 μm mesh and pelleted by centrifuging at
1000 rpm for 5 min. The mature adipocytes were col-
lected and cultivated in adipocyte medium consisting of
Dulbecco’s modified Eagle’s medium (DMEM)/F-12,
100 mL/L FBS, 6 × 104 U/L penicillin, and 6 × 104 U/L
streptomycin. The pellet containing the stroma-vascular
fraction (SVF) was incubated in erythrocyte lysis buffer
(155 mmol/L NH4Cl, 10 mmol/L KHCO3, and 90 μmol/L
EDTA) for 10 min at room temperature. For preadipocyte
differentiation experiments, SVF cells were collected
by centrifugation and, without any filtration step,
grown in medium containing DMEM/F-12, 100 mL/L
FBS, 15 mmol/L HEPES (pH 7.4), 60 U/mL penicillin,
6 × 104 U/L streptomycin, and 25 mg/L amphotericin
B. Cultures were incubated at 37 °C in a 5 % CO2,
water-saturated atmosphere. SVF cells were grown to
70–80 % confluency and then prepared for differenti-
ation, as described in previous publications [23].
For the first 3 d, cultures were grown in differenti-
ation medium containing DMEM/F-12, 30 mL/L FBS,
15 mmol/L HEPES (pH 7.4), 33 mmol/L biotin,
17 mmol/L pantothenate, 100 nmol/L insulin, 1 mmol/L
dexamethasone (DEX), 6 × 104 U/L penicillin, 6 × 104 U/L
streptomycin, 25 mg/L Fungizone and 0.25 mmol/L
3-isobutyl-1-methylxanthine (IBMX). Thereafter, the
medium was replaced every other day without IBMX.
After 10 d, under these culturing conditions, ap-
proximately 35 % of the cells exhibited the morph-
ology of mature adipocytes. After 15 d in culture, at
least 80 % of the cells contained visual lipid drop-
lets. Lipid accumulation was assessed by staining
paraformaldehyde-fixed cells with oil red O and quan-
tified by measuring the optical absorbance at 510 nm.
Insulin and other chemicals were from Sigma–Aldrich
(St. Louis, MO, USA) or as indicated in the text.
THP-1 cell culture and stimulation
A human acute monocytic leukemia cell line (THP-1) was
purchased from China Cell Culture Center (Shanghai,
China) and cultured in standard RPMI 1640 medium
supplemented with 10 % fetal bovine serum (FBS;
GIBCO) in a 5 % CO2, water-saturated atmosphere. For
maturation, THP-1 cells were treated with phorbol-12-
myristate-13 acetate (PMA) (100 ng/mL, Sigma, St. Louis,
MO) for 48 h, after which the medium was aspirated
and the cells were washed twice in pre-warmed PBS
[24]. For polarization toward the M1 or M2 pheno-
type, the PMA-differentiated THP-1 macrophages
were cultured for 96 h in media containing LPS
(100 ng/mL, Calbiochem, Billerica, MA) plus IFN-γ
(20 ng/mL, Sigma) or IL-4 (20 ng/mL, Peprotech, Rocky
Hill, NJ), respectively [25].
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For morphological studies, polarized THP-1 macro-
phages were photographed using differential interference
light microscopy.
The cell phenotypes in each condition were deter-
mined by quantitation of the expression of cell markers
that delineated the M1 and M2 phenotypes by flow cy-
tometry (FCM), as described previously [26]. After the
THP-1 cells had been treated as described above, they
were scraped, followed by washing with ice-cold PBS
and centrifugation. The pellets were stained for 20 min
on ice with CD11c-FITC and CD206-PE antibodies (BD
Biosciences, San Jose, CA, USA) in PBS containing 1 %
FBS. After incubation, the cells were washed with ice-
cold PBS three times and resuspended in 200 μL 1 %
FBS − PBS. Fluorescence intensities were analyzed by a
fluorescence-activated cell sorting (FACS) scan (BD Bio-
sciences, San Jose, CA, USA). All data were analyzed
using FlowJo software (Tree star, Ashland, OR, USA).
Preparation of MVs
MVs were isolated from the THP-1 macrophage culture
medium by differential centrifugation, using a previously
published technique [15, 27]. Briefly, the supernatant
medium was centrifuged at 500 g and then at 1500 g to
spin down the mature cells and cell debris. The resultant
supernatant was filtered through 0.22 μm film and fur-
ther centrifuged at 130,000 g for 70 min (all steps were
performed at 4 °C), and then the pellet at the bottom of
the centrifugation tube was collected (MVs-rich frac-
tion). The BCA method was employed to quantify the
total protein content in the MVs. The levels of MVs
were determined by measuring the total protein content,
which is presented as micrograms of total protein in the
MVs.
Transmission electron microscope (TEM) assay
The MVs were fixed overnight at 4 °C with 2 % glutaral-
dehyde in 0.1 mol/L phosphate buffer (pH 7.4). The
samples were rinsed in PBS buffer and postfixed in 1 %
OsO4 for 1 h, dehydrated in ethyl alcohol, and embed-
ded in Quetol-812. Ultra-thin sections were etched using
saturated sodium metaperiodate, followed by additional
etching in 0.1 N HCl for 10 min before observation with
a FEI Tecnai T20 transmission electron microscope.
Fluorescence labeling of MVs and confocal microscopy
analysis
Macrophage-like THP-1 (M0 THP-1) cells were labeled
with DiI-C16 for 2 h and washed three times with PBS.
The cells were resuspended and cultured for 24 h in
1640 medium supplemented with 10 % FBS. The su-
pernatants were then collected and centrifuged to
harvest M0 THP-1-secreted MVs (M0 MVs). M0 MVswere re-suspended in PBS and incubated with cultured
human preadipocytes. After a fixed time interval (0, 2,
or 4 h), preadipocytes were washed, fixed, and observed
with confocal microscopy (FV1200; Olympus, Tokyo).
The pictures were taken under these conditions: Objective
Lens: LUCPLFLN 40×; Scan Mode: XY; Excitation
Wavelength: 342 nm for Hoechst and 546 nm for
DiI-C16; Image Size: 1024 × 1024 Pixel.
Quantitative real-time PCR
The qRT-PCR analysis was performed in 96-well plates
using SYBR Green-based detection on a StepOnePlus
machine (Applied Biosystems, Norwalk, CT, USA). Each
10 μL reaction contained approximately 50 ng of cDNA,
0.3 μM of sense and antisense primers, and 1× Quanti-
Tect SYBR Green SuperMix (TaKaRa, Japan). The plate
was then sealed and cycled under the following conditions:
95 °C /10 min; 40 cycles of 95 °C /10 s and 60 °C /45 s.
Each reaction was performed in triplicate, using mRNA
levels of β-actin for normalization. The sequences of the
primers were as follows: CD68 (forward 5′-GCTACA
TGGCGGTGGAGTACAA-3′; reverse 5′-ATGATGAG
AGGCAGCAAGATGG-3′) TNF-α (forward 5′-CCCA
GGCAGTCAGATCATCTTCT-3′; reverse 5′-ATGAG
GTACAGGCCCTCTGAT-3′); CD206 (forward 5′-CC
ATGGACAATGCGCGAGCG-3′; reverse 5′-CACCTG
TGGCCCAAGACACGT-3′); PPARγ1 (forward 5′-ATT
CTGGCCCACCAACTTTG-3′; reverse 5′-TCCATTAC
GGAGAGATCCACG-3′); PPARγ2 (forward 5′- AGC
AAACCCCTATTCCATGCT-3′; reverse 5′- ATCAG
TGAAGGAATCGCTTTCTG-3′) and β-actin (forward
5′-CACGAAACTACCTTCAACTCC-3′; reverse 5′- C
ATACTCCTGCTTGCTGATC-3′).
Nuclear extract preparation
Nuclear proteins were prepared as previously described
[28]. After the indicated treatments, adipocytes were
washed three times and resuspended in buffer A
[(10 mmol/L KCl, 0.1 mmol/L EDTA, 0.1 mmol/L
EGTA,10 mmol/L HEPES; pH 7.9), 1 mmol/L DTT,
and 0.5 mmol/L PMSF], followed by centrifugation
(10 min, 3000 g at 4 °C). The supernatant was then dis-
carded and the pellet was resuspended in buffer A.
After a 15 min incubation on ice, a 1:20 volume of
10 % Nonidet P-40 was added and vortexed. The nuclei
were allowed to swell on ice for 15 min and then were
pelleted by centrifugation (10 min, 10,000 g at 4 °C).
The resulting nuclear extracts were frozen and stored
at −80 °C.
Western blotting
Adipocytes or MVs were lysed with ice-cold lysis
buffer containing 50 mmol/L Tris–HCl (pH 7.4), 1 %
NP-40, 150 mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L
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hibitor (1 tablet/10 mL; Roche). After centrifugation at
12,000 rpm for 20 min at 4 °C, the supernatants were col-
lected and protein concentration was determined by the
BCA Protein Assay (Thermo Scientific Pierce, Rockford,
IL). Proteins (40–60 μg protein/lane) were separated by
electrophoresis on 10–12 % polyacrylamide gels, and the
bands were subsequently transferred onto polyvinylidene
fluoride (PVDF) membranes (Millipore). Membranes were
blocked in PBST/5 % nonfat dry milk powder and incu-
bated with antibodies against TSG101 and NF-κB p65
(Santa Cruz Biotechnology, Santa Cruz, CA), GLUT4
(Abcam, Cambridge, UK), phosphorylated Akt (Ser473),
Akt and clathrin heavy chain (Cell Signaling Technology,
Danvers, MA). Anti-human Akt, clathrin, and histone H3
(Santa Cruz Biotechnology, Santa Cruz, CA) were used as
controls.
Plasma membrane proteins from treated adipocytes
were prepared using Sigma-Aldrich Proteo-Prep Mem-
brane Extraction Kit [29]. Aliquots containing 80 μg of
plasma membrane protein were subjected to 10 %
SDS-PAGE, and Western blot analysis was performed
as described above.
Measurement of cytokine release
Human Interleukin (IL)-10 and IL-1β levels were
assayed in cell culture supernatants by sandwich
enzyme-linked immunosorbent assay (ELISA) using a
commercially available ELISA kit (R&D Systems, Min-
neapolis, MN, USA), according to the manufacturer’s
instructions.
Glucose uptake measurement by 2-NBDG
The glucose uptake assay with the 2-NBDG screening
system was performed as previously described, with
some modifications [30]. Briefly, human primary preadi-
pocytes were first differentiated in 96-well plates and
then cultured for 24 h in DMEM/F12 medium contain-
ing 100 μg of the indicated MVs. After 24 h, adipocytes
were washed in Krebs-Ringer phosphate (KRP) buffer
(pH 7.4) (136 mmol/L NaCl, 4.5 mmol/L KCl,
1.25 mmol/L CaCl2, 1.25 mmol/L MgCl2, 0.6 mmol/L
Na2HPO4, 0.4 mmol/L NaH2PO4, 10 mmol/L HEPES,
and 0.1 % BSA), and incubated at 37 °C for 20 min in
50 μL KRP with the given concentration of insulin. The
cells were then sequentially cultured with or without
10 mM 2-NBDG in 50 μL KRP for a further 1 h. The
fluorescence intensity of 2-NBDG was recorded using
an F-7000 fluorescence spectrophotometer (Hitachi,
Tokyo, Japan). False positives were ruled out by treat-
ing with MVs in the absence of 2-NBDG and using
these measurements as the background. The relative
fluorescence intensities minus the background levels
were used for data analysis.MTT assay
The preadipocytes were seeded at a density of 1 × 104
cells/well in 96-well culture plates. Then, the cells were
treated with BAY 11–7082 at the various concentrations
(2.5, 5, 10 and 20 μM) for 24 h. After completion of the
treatment, the cells were incubated with MTT (Sigma-
Aldrich, USA) solution (2 mg/mL) for 4 h at 37 °C. The
supernatants were aspirated, DMSO was added, and the
plates were agitated to dissolve the crystal product.
Absorbance was measured at 490 nm (570 nm as a ref-
erence) using a StatFAX303 plate reader.
Data analysis
The western blot images are representative of at least
three independent experiments. The values for the FCM,
qRT-PCR, ELISA, 2-NBDG and MTT assays were from
three independent experiments performed in triplicate.
The data are expressed as the mean ± SEM of three in-
dependent experiments. Statistical significance was de-
termined using Student’s t-test and set as P < 0.05.
Results
Characterization of polarized macrophages
Differentiated THP-1 monocytes have been widely used
as an in vitro model of human macrophages. Classically
(M1) or alternatively (M2) activated macrophage popula-
tions were derived from THP-1 cells by conducting ser-
ial dose and time optimization experiments. As shown
in Fig. 1a, light microscopy showed that monocyte-like
THP-1 cells (THP-1) displayed a round shape and a
nonadherent pattern, while macrophage-like THP-1 cells
(M0, M2 and M1 THP-1) were adherent, with the typ-
ical flat, amoeboid-shaped, elongated, and branching
macrophage morphology. The macrophage-like THP-1
(M0 THP-1) phenotype was also illustrated by the in-
crease in CD68 mRNA revealed by the qRT-PCR assay
(Fig. 1b). Most importantly, another feature of M2 and
M1 THP-1 macrophage polarization was enhanced
marker gene and protein expression, as confirmed by
qRT-PCR and FCM quantification assays. Fig. 1c shows
that, in contrast to M0 THP-1 cells, M1 THP-1 cells
preferentially expressed pro-inflammatory genes (i.e.,
TNF-α), whereas M2 THP-1 cells mainly expressed
anti-inflammatory genes (e.g., the macrophage mannose
receptor, CD206). FCM quantification of M1 THP-1
cells also showed an increased level of CD11c, which is
crucial for the activation of M1 macrophage, and a de-
creased level of CD206 as compared with M2 THP-1
cells (Fig. 1d). The M1 and M2 THP-1 phenotypes were
confirmed by characterization of secreted cytokines. As
expected, M1 THP-1 cells significantly enhanced the se-
cretion of IL-1β, a master proinflammatory cytokine
(Fig. 1f ), whereas M2 THP-1 cells mostly secreted IL-10
into the medium (Fig. 1e). Collectively, these results
Fig. 1 Detection of macrophage polarization. a. Morphology of THP-1 monocytes, M0 THP-1, M2 THP-1, and M1 THP-1 cells were examined by
light microscopy (100×). b, c. Phenotypic gene expression in M0 THP-1, M1 THP-1, and M2 THP-1 cells was analyzed by qRT-PCR. d. Expression of
CD11c and CD206 was determined by flow cytometry. Quantification of the flow cytometry assay was analyzed using FlowJo software, and statistical
analysis is presented below. e, f. IL-10 (e) and IL-1β level (f) in the cell culture supernatant were analyzed by ELISA. **P < 0.01 indicates a significant
difference compared with the corresponding vehicle groups. ***P< 0.001 indicates a significant increase when compared with the indicated conditions
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into M1-like or M2-like macrophages after PMA, LPS
plus IFN-γ, or IL-4 stimulation.
Internalization of macrophage-derived MVs into
adipocytes
Previously, studies by our laboratory [15] and others
[31] have demonstrated that MVs derived from
monocyte-like THP-1 cells can enter into recipient
cells. Accordingly, we tested whether macrophage-like
THP-1-secreted MVs (e.g. M0 MVs) can enter the adi-
pocytes. We first characterized the MVs shed by
macrophage-like THP-1 cells by TEM and western blot
assays. As shown in Fig. 2a (indicated by red arrows),
the isolated macrophage-like THP-1 MVs were vesicles
30–100 nm in diameter, and each of these vesicles was
surrounded by a double-layer membrane, which was
consistent with monocyte-like THP-1 cell-derived MVs
(THP-1 MVs). Meanwhile, the ubiquitin-binding protein
and exosome marker TSG101 [32] was highly expressed
in the MVs (Fig. 2b). Interestingly, these vesicles were alsotaken up by adipocytes. Fluorescence-labeled M0 MVs
were incubated with unstained adipocytes. As depicted in
Fig. 2c, labeled MVs rapidly entered the recipient cells;
this uptake was an active process that depended on the in-
cubation time. This experiment clearly demonstrated that
macrophage-secreted MVs could be effectively internal-
ized into adipocytes.
Effect of macrophage-derived MVs on insulin signaling in
human adipocytes
The effects of MVs [derived from M1 THP-1 (M1 MVs)
and M2 THP-1 (M2 MVs) macrophages] on insulin sig-
naling were examined by measuring the phosphorylation
of the serine/threonine kinase Akt (pAkt), a central
player in the insulin signaling pathway. Human primary
mature adipocytes were used as they represent a primary
cell type for insulin action and the development of in-
sulin resistance in obesity. These adipocytes were iso-
lated and cultivated in complete DMEM/F-12 medium
(Additional file 1: Figure S1A), followed by a 24 h
treatment with various concentrations of M1 MVs and
Fig. 2 Internalization of macrophage-derived MVs into adipocytes. a. Micrographs of MVs isolated from culture medium of THP-1 monocytes and
polarized THP-1 macrophages examined by TEM. These particles are highlighted by red arrows. Scale bars are all equal to 100 nm. b. Equal
amounts of proteins from indicated MVs were analyzed using western blotting for exosome-enriched protein TSG10. Western blot images were
analyzed by Bandscan software, and statistical analysis is presented below. c. Internalization of fluorescently labeled M0 MVs into adipocytes was
analyzed by confocal microscopy (400×)
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insulin for 20 min. M0 MVs was employed as a normal
control. Fig. 3a shows that treatment with 100 μg M1
MVs significantly reduced the level of pAkt, whereas
treatment with M2 MVs applied at the same concen-
tration mainly induced pAkt expression, when com-
pared with M0 MVs-treated cells. Thus, 100 μg MVs
were used in all further experiments in this study.
The impact of MVs on insulin signaling was investi-
gated by pretreating human subcutaneous adipocytes
with the indicated MVs for 24 h, and then incubating
the cells with various concentrations of insulin for
20 min, followed by analysis of pAkt expression. Fig. 3b
shows that the level of pAkt was significantly increasedafter insulin stimulation, in a dose-dependent manner.
Importantly, M1 MVs consistently induced a marked re-
duction of pAkt level in response to 100 nM insulin
(Fig. 3b, lane 14), in contrast to the higher pAkt level
observed following M2 MVs treatment (Fig. 3b, lane 10),
when compared to the M0 MVs-treated control.
We also assessed the role of M1 MVs and M2 MVs on
insulin-stimulated pAkt in differentiated human adipo-
cytes. A homogenous adipocyte fraction was obtained by
isolating human primary pre-adipocytes (Additional file
1: Figure S1B) and differentiating these into adipocytes;
this differentiation was morphologically monitored
(Fig. 4a, b). As expected, qRT-PCR assays also con-
firmed a significant up-regulation of two mRNA markers
Fig. 3 Effects of macrophage-derived MVs on insulin-stimulated Akt phosphorylation in human mature adipocytes. a. The level of pAkt in human
mature adipocytes after treatment with various concentrations of M0 MVs, M1 MVs, and M2 MVs was detected by western blot assays. Ethanol
treatment was used as the negative control, and the palm group was the positive control. Western blot images were analyzed using Bandscan
software, and statistical analysis is presented below. b. Levels of insulin-stimulated pAkt protein in adipocytes after treatment with indicated MVs
were determined by western blotting. PBS treatment was used as the basal control. Quantification of the pAkt protein levels is shown below.
**P < 0.01 indicates a significant enhancement compared with the corresponding vehicle control. #P < 0.05 indicates a significant difference when
compared with the indicated conditions
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activated-receptor γ1 (PPARγ1, fold-changes control =
20, p < 0.001) and PPARγ2 (fold-changes control = 80,
p < 0.001), which are key regulators of adipogenesis.
Both were highly expressed in adipocytes compared to
pre-adipocytes (Fig. 4c). The differentiated adipocytes
were then pre-treated with the indicated MVs followed
by stimulation by various concentrations of insulin.Fig. 4d shows that stimulation with 100 nM insulin and
M1 MVs inhibited of Akt phosphorylation (lane 14),
whereas M2 MVs treatment reversed this response
in treated adipocytes (lane 10), compared with M0
MVs-treated control (lane 6). Taken together, these
results suggest that macrophage-derived MVs may
functionally regulate insulin signaling and that M1
MVs may play a critical role in decreasing insulin
Fig. 4 Roles of macrophage-derived MVs in insulin-stimulated pAkt levels in human differentiated adipocytes. a. Human differentiated adipocytes
were fixed and stained with oil red O for lipid accumulation. (200×). b. The optical absorbance of lipid accumulation was measured at 510 nm. c.
The mRNA levels of PPARγ1 and PPARγ2 in preadipocytes and adipocytes were analyzed by qRT-PCR. d. Protein levels of pAkt in human differentiated
adipocytes were detected by western blotting. Adipocytes were pretreated with various reagents for 24 h, and then the cells were stimulated with 0,
1, 10, or 100 nM insulin for 20 min, lysed with lysis buffer, and prepared for the immunoblotting assay. Total Akt (tAkt) was used as a loading control.
Western blot images were analyzed using Bandscan software, and statistical analysis is presented below. *P < 0.05, **P < 0.01 and ***P < 0.001 indicate
a significant up-regulation compared with the corresponding vehicle groups. #P < 0.05 and ###P < 0.001 indicate significant difference when compared
with indicated conditions
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have the opposite effect.
Effect of macrophage-derived MVs on insulin-induced
glucose uptake in human adipocytes
The effects of macrophage-derived MVs on insulin sen-
sitivity were further assessed by assaying 2-NBDG up-
take in terminally differentiated adipocytes following
treatment with indicated MVs for 24 h, followed by
stimulation with various concentrations of insulin for
20 min. As illustrated in Fig. 5a, insulin induced a dose-
dependent increase in glucose uptake in human differen-
tiated adipocytes. Compared with the M0 MVs treated
control, M1 MVs markedly decreased glucose uptake
into treated adipocytes, whereas M2 MVs clearly en-
hanced this uptake following 100 nM insulin stimulation
(Fig. 5a).The possibility that the reduction (or enhancement) of
glucose uptake into adipocytes could be explained by
M1 MVs/M2 MVs-induced changes in the amounts of
glucose transporter protein at the cell surface was
addressed by measuring the protein level of GLUT4,
one of the predominant glucose transporter isoforms
expressed in adipocytes. GLUT4 levels were measured
in plasma membrane (PM) fractions in the basal state or
after treatment with M1 MVs or M2 MVs, following in-
cubation with or without 100 nM insulin. PM fractions
prepared from basal (PBS and M0 MVs-treated group),
M1 MVs-treated and M2 MVs-treated adipocytes con-
tained comparable amounts of clathrin [34]. In the ab-
sence of insulin, the PMs of human mature adipocytes
(Fig. 5b, lane 1) and differentiated adipocytes (Fig. 5c,
lane 1) contained only low amounts of GLUT4. Insulin
exposure (100 nM) substantially increased the GLUT4
Fig. 5 Effects of macrophage-derived MVs on glucose uptake and GLUT4 translocation in human adipocytes. a. The insulin-stimulated glucose
uptake of treated differentiated adipocytes was measured by 2-NBDG assay. The relative fluorescence intensities minus the background levels
were used for statistical analysis. b, c. The level of GLUT4 in plasma member (PM) fractions of human mature adipocytes (b) and differentiated
adipocytes (c) was determined by western blotting. Adipocytes were treated with the indicated MVs for 24 h, and were then treated with or without
100 nM insulin for a further 20 min. Cells were homogenized, and PM fractions were obtained and subjected to immunoblotting with antibodies
against GLUT4, or clathrin heavy chain, as indicated. Western blot images were analyzed using Bandscan software, and statistical analysis is presented
below. *P < 0.05 and **P < 0.01 indicate a significant augmentation compared with the corresponding vehicle treated control. #P < 0.05 and ##P < 0.01
indicate significant a difference when compared with the indicated conditions
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previously reported findings [35]. Notably, M2 MVs
induced a significant increase in the GLUT4 protein of
the PMs (Fig. 5b and c, lane 6), whereas M1 MVs were
less effective than M2 MVs at inducing PM transloca-
tion of GLUT4 (Fig. 5b and c, lane 8), when compared
to the M0 MVs-treated group (Fig. 5b and c, lane 4).
The M1 MVs-induced decrease in glucose uptake was
associated with the presence of only half the amount of
GLUT4 in the PM fraction, whereas M2 MVs increased
GLUT4 levels in the PM. Collectively, these results indi-
cate that, compared with M2 MVs, M1 MVs induce amarked reduction of glucose uptake activity by decreas-
ing the translocation of GLUT4 to the adipocyte PM.
Effect of macrophage-derived MVs on insulin-stimulated
activation of NF-κB in human adipocytes
Nuclear factor kappa B (NF-κB) is a transcription factor
that is thought to play a central role in obesity-
associated inflammation and insulin resistance [36]. In a
quiescent state, NF-κB is confined to the cytoplasm by
the inhibitor of κB-α (IκBα). The activated inhibitor of
the kappa B kinase complex (IKK) phosphorylates IκBα,
which leads to IκBα polyubiquitination and degradation,
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where it induces target gene expression [37]. The possi-
bility that M1 MVs and M2 MVs might mediate the ef-
fect of NF-κB activation on insulin signaling and glucose
uptake in adipocytes was evaluated by analyzing the
levels of NF-κB p65 in nuclei of human mature adipo-
cytes and differentiated adipocytes, following treatment
with indicated MVs and insulin. Fig. 6a and b show that
stimulation by 100 nM insulin strongly increased the
basal level of nuclear NF-κB p65 (PBS group, lane 2) in
mature (Fig. 6a) and differentiated adipocytes (Fig. 6b),Fig. 6 Effect of macrophage-derived MVs on insulin-stimulated activation o
NF-κB p65 in human mature adipocytes (a) and differentiated cells (b) wer
indicated MVs for 24 h, and then incubated with 0, 1, 10, or 100 nM of insu
determined by immunoblotting. Quantification of NF-κB p65 protein level
software, and statistical analysis is presented below. *P < 0.05 and **P < 0.01
vehicle-treated control. #P < 0.05 and ##P < 0.01 indicate a significant differin agreement with previous findings showing that insulin
activates NF-κB in mammalian cells [38]. The expression
of NF-κB was increased upon treatment with insulin in
a dose-dependent manner. Compared with M0 MVs
(Fig. 6a and b, lane 6), the level of NF-κB p65 in nuclei
was significantly increased after M1 MVs treatment
(Fig. 6a and b, lane 14), whereas the nuclear marker
protein, histone H3, was not affected by M1 MVs treat-
ment. In contrast, incubation with M2 MVs strongly
decreased the level of nuclear NF-κB p65 in adipocytes
(Fig. 6ba and , lane 10).f NF-κB in human adipocytes. a, b. Relative protein levels of nuclear
e analyzed by western blotting. Human adipocytes were treated with
lin for 20 min. NF-κB p65 and histone H3 levels in nuclear lysates were
is shown below. Western blot images were analyzed using Bandscan
indicate a significant enhancement compared with the corresponding
ence when compared with the indicated conditions
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gering of insulin resistance in adipocytes was further
evaluated by treatment with BAY 11–7085, a reversible
small molecule inhibitor of IκBα phosphorylation (Bay
hereafter) [39]. Fig. 7a and d show that a 2 h prestimula-
tion of mature adipocytes (Fig. 7a) and differentiated
adipocytes (Fig. 7d) with 10 μM Bay (a concentration
shown to be effective in reducing p65 activity) [40] did
not affect adipocyte viability, as assessed by the MTT
assay (Additional file 2: Figure S2). Subsequent treat-
ment with M1 MVs resulted in a pronounced reduction
in the level of nuclear NF-κB in the Bay treated cells
compared to cells not treated with Bay. The same treat-
ment condition also significantly enhanced the expres-
sion of pAkt (Fig. 7b, e) and GLUT4 translocation
(Fig. 7c, f ). Taken together, our results suggest that M1Fig. 7 Blocking of NF-κB reverse the inhibitory effect of M1 MVs on pAkt leve
nuclear NF-κB p65 in human mature adipocytes (a) and differentiated cells (d
without NF-κB specific inhibitor (Bay, 10 μM) for 2 h, then incubated with M1
H3 level after insulin stimulation for a further 20 min. Quantification of NF-κB
mature adipocytes (b) and differentiated adipocytes (e), after treatment as in
statistical analysis is presented below. c, f. The levels of GLUT4 in plasma mem
adipocytes (f) were determined by western blotting. Cells were treated as in A
the indicated antibodies. Quantification of the GLUT4 protein level is show
corresponding vehicle-treated controlMVs-mediated changes in insulin signaling and glucose
uptake may be dependent on their modulation of NF-κB
activity.
Discussion
During the progression of obesity, an accumulation of
macrophages and other immune cells occurs in adipose
tissue [41]. The resulting reinforcement of macrophage-
adipocyte crosstalk in obesity affects adipose tissue biol-
ogy; however, the molecular mechanisms and the key
mediators, particularly those in human adipose tissue,
are still poorly understood. This work used in vitro
models of human macrophages (a macrophage-like THP-1
cell line) and primary adipocytes to investigate the role of
polarized macrophage-derived MVs on insulin signal
transduction and glucose uptake in human adipocytes.l and GLUT4 translocation in human adipocytes. a, d. Expression level of
) were analyzed by western blotting. Adipocytes were pretreated with or
MVs for 24 h. Nuclear lysates were analyzed for NF-κB p65 and histone
p65 protein level is presented below. b, e. Protein level of pAkt in human
a. Western blot images were analyzed using Bandscan software, and
brane (PM) fractions of human mature adipocytes (c) and differentiated
, and PM fractions were obtained and subjected to immunoblotting with
n below. *P < 0.05 indicates a significant difference compared with
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macrophages (M1 MVs) decreased the insulin-stimulated
phosphorylation of Akt protein through enhancement of
NF-κB activation and they blocked glucose uptake by
blunting signaling responses that lead to glucose trans-
porter (GLUT4) translocation to the cell surface. By con-
trast, MVs secretion by anti-inflammatory macrophages
(M2 MVs) significantly induced pAkt expression, which
evoked an increase in glucose transport into the adipo-
cytes. This implicates M1 MVs as important factors for
aggravating insulin resistance in obese adipose tissue,
whereas M2 MVs may reverse this effect. This possibility
could be important for developing effective therapeutic
targets.
Our previous study demonstrated that monocytic
THP-1 (myeloid leukemic cell line)-secreted MVs could
communicate with a variety cell types, such as human
microvascular endothelial cells [15] and tumor-associated
macrophages [42], suggesting that these MVs may have a
widespread impact. Therefore, in this study, we employed
THP-1-derived macrophages as a cell model to detect the
effect of MVs secreted by macrophage-like THP-1 cells
on human adipocytes. We found that MVs shed by
monocyte-like THP-1 and macrophage-like THP-1 cells
have a uniform vesicular structure and a greater expres-
sion of the exosomal marker protein TSG101. The MVs
derived from macrophages are also capable of internal-
izing into adipocytes in a time-dependent manner, as
determined using labeled MVs; this uptake is essential
for mediation of adipocyte responses independently of
cytokines.
Identification of the key factors that mediate the detri-
mental effects of macrophages on adipocytes is crucial
for the development of effective therapeutic targets.
Macrophage-derived cytokines have been implicated as
key regulators in the transformation of obesity-associated
inflammation into insulin resistance in rodents and
humans. For example, Medina et al. reported that
macrophage-derived TNF-α played a key role in impair-
ing Akt-dependent insulin signaling in adipocytes by de-
creasing Akt levels [43]. Lagathu et al. demonstrated
that IL-1β, released by macrophages, mediates the effect
on insulin signaling transduction and proinflammatory
response in human primary adipocytes through effects
on the insulin signaling pathway [6]. IL-6-secreted by
macrophages also impaired insulin signaling and action
in 3 T3-L1 adipocytes through effects on gene transcrip-
tion of IRS-1, GLUT4, and PPARγ [7, 44].
However, the onset of insulin resistance presents an
interesting challenge because of its multifactorial char-
acter. In addition to secreted cytokines, other factors
in adipose tissue may contribute to the adipocyte-
macrophage interaction. In the present study, we showed
that, as is seen with cytokines, M1 MVs (inflamedmacrophage-secreted MVs) also substantially inhibited the
insulin signaling pathway in human adipocytes. Akt phos-
phorylation is a key enzyme modification involved in insu-
lin signaling [45] and the level of pAkt was significantly
increased with insulin stimulation in a dose-dependent
manner. When compared with M0 MVs, M1 MVs signifi-
cantly decreased Akt signaling in response to insulin (100
nM) stimulation in both human mature and differentiated
adipocytes, whereas M2 MVs dramatically increased pAkt
level and enhanced Akt signaling. These findings suggest
that M1 MVs may potentially inhibit Akt phosphorylation,
and may serve as a potential mediator for the inhibition of
insulin signaling by macrophage activation.
Glucose homeostasis is determined by glucose produc-
tion and utilization in the insulin-sensitive organs and
tissues, including muscle, liver, and adipose tissue. Glu-
cose uptake in adipose tissue plays a critical role in the
body glucose control [46], which is demonstrated by the
selective depletion of GLUT4 in adipose tissues of mice
[47]. In this study, we observed insulin stimulation of
glucose uptake in adipocytes in a dose-dependent man-
ner in control or MVs-treated conditions. In the pres-
ence of 100 nM insulin, M1 MVs significantly decreased
glucose uptake by blocking GLUT4 (insulin-dependent
glucose transporter) translocation in adipocytes, as com-
pared to M0 MVs treated adipocytes, while treatment
with M2 MVs gave an opposite response. The results
shown in Figs. 3 and 4 indicate that the suppression of
protein phosphorylation and glucose transport resulted
mainly from the interaction of MVs and adipocytes,
where MVs derived from inflamed macrophages blunted
insulin action in adipocytes. Therefore, MVs secreted by
inflammation-activated macrophages may serve as po-
tential inhibitors of insulin signaling and lead to insulin
resistance in adipocytes.
The role played by MVs in insulin signaling is complex
because of the heterogeneous and unknown contents
(proteins, RNAs, lipid, etc.) of MVs that could be provid-
ing the signal(s) to modulate the function of recipient
cells. The mechanisms by which M1 MVs can interfere
with insulin signaling and glucose uptake in adipocytes
are currently unknown. The nuclear IKK/NF-κB [36]
signaling pathway has been well characterized and medi-
ates the inflammatory responses that further exacerbate
insulin sensitivity and glucose/lipid homeostasis [48].
We explored the possible mechanism of MVs action by
examining the nuclear translocation of NF-κB, a hall-
mark of NF-κB activation, in MVs-treated adipocytes.
We clearly demonstrated the involvement of NF-κB acti-
vation in the observed decrease in pAkt expression and
GLUT4 translocation elicited by M1 MVs in adipocytes.
First, we found that insulin induced the activation of
NF-κB in a dose-dependent manner, in accordance with
previous studies [38]. Second, compared with M2 MVs,
Zhang et al. Nutrition & Metabolism  (2015) 12:21 Page 13 of 14M1 MVs showed pro-inflammatory activities evoked by
enhancement of NF-κB nuclear translocation. Treatment
with Bay, which inhibits NF-κB by prevention of entry of
the p65 subunit into the nucleus, resulted in marked
down-regulation of NF-κB p65 translocation in M1
MVs-treated cells. Third, we found that adipocytes pre-
treated with Bay had clearly increased levels of pAkt and
GLUT4 translocation following M1 MVs treatment.
NF-κB has no known phosphatase activity, so NF-κB
might not have a direct action on the insulin-signaling
pathway. The role of NF-κB in insulin action needs fur-
ther research. We speculate the MVs derived from M1
macrophages may form inflammasomes that induce the
inflammation of fat cells. The NF-κB-dependent inflam-
matory pathway is then activated and this leads to
disruption of insulin signaling and glucose transport.
The actual molecular signal packaged inside the MVs re-
mains to be determined in future research.Conclusions
The results of the current study indicate that MVs de-
rived from inflamed macrophages (M1 MVs) play a role
in reducing insulin signal transduction and in decreasing
insulin-stimulated glucose uptake in human adipocytes
by activation of NF-κB. This may represent a novel
mechanism of insulin resistance in adipose tissue, which
makes MVs attractive candidates for insulin resistance
therapy.Additional files
Additional file 1: Figure S1. Light microscopy images of adipocytes. A.
Image of human primary mature adipocytes isolated from adipocyte
tissue was examined by light microscopy (100×). B. Image of human
preadipocytes isolated and cultivated for 3 d was obtained by light
microscopy (100×).
Additional file 2: Figure S2. The survival rate of pre-adipocytes was
determined by MTT after treatment with indicated concentration of BAY
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